Ethinyl Estradiol / Inert Ingredients / Norethindrone
Also known as: Alyacen, Aranelle 28, Balziva 28, Briellyn, Dasetta, Dasetta 7/7/, Femlyv, Necon, Nortrel, Nylia, Philith, Vyfemla and 1 more.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Class |
|---|---|---|---|
| 0.035 MG | Tablet | $0.466 / unit | Generic |
| 0.4 MG-0.035 MG | Tablet | $0.323 / unit | Generic |
| 0.4-0.035 MG | Tablet | $0.323 / unit | Generic |
| 0.5-35-28 | Tablet | $0.466 / unit | Generic |
| 1-35 | Tablet | $0.206 / unit | Generic |
| 1-35-28 | Tablet | $0.206 / unit | Generic |
| 1 MG-0.02 MG | Tablet | $6.77 / unit | Brand |
| 7-7-7-28 | Tablet | $0.245 / unit | Generic |
| 7-28 | Tablet | $0.245 / unit | Generic |
| — | Tablet | $0.465 / unit | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Brand list prices fall after confidential rebates.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $2,677,035 gross for Ethinyl Estradiol / Inert Ingredients / Norethindrone across 101,056 prescriptions (measured, national).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS